MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 4:200-214, (2004)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.4.4.4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, M. B.
Right arrow Articles by Hooks, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, M. B.
Right arrow Articles by Hooks, S. B.
Review

The Gß{gamma} DIMER as a NOVEL SOURCE of SELECTIVITY in G-Protein Signaling: GGL-ing AT CONVENTION

Miller B. Jones, David P. Siderovski1 and Shelley B. Hooks

Department of Pharmacology and
1 UNC Neuroscience Center and Lineberger Comprehensive Cancer Center, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7365


Heterotrimeric G proteins relay information between cell surface receptors and effector molecules in diverse signaling pathways to mediate critical cellular processes in both physiologic and pathologic conditions. Multiple isoforms of each of the three G protein subunits yield enormous structural and functional diversity. G proteins are thus obvious molecular targets for the therapeutic manipulation of signaling pathways. Their ubiquity among a vast array of G protein–coupled receptor pathways, however, may at first seem to threaten the attractiveness of G proteins as drug targets for specific signaling processes; in order for G proteins to be effective targets, some degree of selectivity must be defined and exploited. Although a great deal has been determined about the functional selectivity of G{alpha} subunits, relatively little is known regarding Gß{gamma} selectivity. In this review, we discuss functional diversity among Gß{gamma} subunits in both receptor coupling and effector activation. The novel functions of Gß5, in complex with proteins of the GGL domain–containing R7 subfamily of regulators of G protein signaling, are discussed in detail, with specific focus on the potential of the Gß5–RGS9-2 pair as a therapeutic target in Parkinson’s disease.




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. A. Yost, S. M. Mervine, J. L. Sabo, T. R. Hynes, and C. H. Berlot
Live Cell Analysis of G Protein beta5 Complex Formation, Function, and Targeting
Mol. Pharmacol., October 1, 2007; 72(4): 812 - 825.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. E. Zeller and H. G. Dohlman
Illuminating Gbeta5 Signaling
Mol. Pharmacol., October 1, 2007; 72(4): 810 - 811.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J.-C. Twizere, J.-Y. Springael, M. Boxus, A. Burny, F. Dequiedt, J.-F. Dewulf, J. Duchateau, D. Portetelle, P. Urbain, C. V. Lint, et al.
Human T-cell leukemia virus type-1 Tax oncoprotein regulates G-protein signaling
Blood, February 1, 2007; 109(3): 1051 - 1060.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. W. Tedford and G. W. Zamponi
Direct G Protein Modulation of Cav2 Calcium Channels
Pharmacol. Rev., December 1, 2006; 58(4): 837 - 862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. A. Wells, J. Dingus, and J. D. Hildebrandt
Role of the Chaperonin CCT/TRiC Complex in G Protein beta{gamma}-Dimer Assembly
J. Biol. Chem., July 21, 2006; 281(29): 20221 - 20232.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. M. Mervine, E. A. Yost, J. L. Sabo, T. R. Hynes, and C. H. Berlot
Analysis of G Protein beta{gamma} Dimer Formation in Live Cells Using Multicolor Bimolecular Fluorescence Complementation Demonstrates Preferences of beta1 for Particular {gamma} Subunits
Mol. Pharmacol., July 1, 2006; 70(1): 194 - 205.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. H. Song, J. J. Waataja, and K. A. Martemyanov
Subcellular Targeting of RGS9-2 Is Controlled by Multiple Molecular Determinants on Its Membrane Anchor, R7BP
J. Biol. Chem., June 2, 2006; 281(22): 15361 - 15369.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. M. Drenan, C. A. Doupnik, M. P. Boyle, L. J. Muglia, J. E. Huettner, M. E. Linder, and K. J. Blumer
Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family
J. Cell Biol., May 23, 2005; 169(4): 623 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. A. Martemyanov, P. J. Yoo, N. P. Skiba, and V. Y. Arshavsky
R7BP, a Novel Neuronal Protein Interacting with RGS Proteins of the R7 Family
J. Biol. Chem., February 18, 2005; 280(7): 5133 - 5136.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.